Mainit, Rosety-an O.

HRN: 18-85-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFUROXIME 1.5GM (VIAL)
05/30/2022
05/31/2022
IVT
1.5gm
IVT Now Then Q8 X 2 More Doses
Primary LTCS With PPIUD
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: